The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting

被引：33
作者：
Menting, S. P. [1 ]
Van den Reek, J. M. P. A. [2 ]
Baerveldt, E. M. [3 ]
De Jong, E. M. G. J. [2 ]
Prens, E. P. [3 ]
Lecluse, L. L. A. [1 ]
Wolbink, G. J. [4 ]
Van der Kleij, D. [4 ,5 ]
Spuls, Ph. I. [1 ]
Rispens, T. [4 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands
[4] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands
[5] Sanquin Diagnost Serv, Biol Lab, Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2015年 / 173卷 / 03期
关键词：
RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; IMMUNOGENICITY; ADALIMUMAB;
D O I：
10.1111/bjd.13834
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：855 / 857
页数：3
相关论文
共 10 条
  • [1] A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interieukin-12/23 monoclonal antibody in subjects with plaque psoriasis
    Gottlieb, Alice B.
    Cooper, Kevin D.
    McCormick, Thomas S.
    Toichi, Eiko
    Everitt, Daniel E.
    Frederick, Bart
    Zhu, Yaowei
    Pendley, Charles E.
    Graham, Martin A.
    Mascelli, Mary Ann
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1081 - 1092
  • [2] Differential effect of drug interference in immunogenicity assays
    Hart, Margreet H.
    de Vrieze, Henk
    Wouters, Diana
    Wolbink, Gerrit-Jan
    Killestein, Joep
    de Groot, Els R.
    Aarden, Lucien A.
    Rispens, Theo
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 372 (1-2) : 196 - 203
  • [3] Antidrug antibodies in psoriasis: a systematic review
    Hsu, L.
    Snodgrass, B. T.
    Armstrong, A. W.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (02) : 261 - 273
  • [4] Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
    Kimball, A. B.
    Papp, K. A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K. B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (12) : 1535 - 1545
  • [5] Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis One-Year Follow-up
    Menting, Stef P.
    van Lumig, Paula P. M.
    de Vries, Anna-Christa Q.
    van den Reek, Juul M. P. A.
    van der Kleij, Desiree
    de Jong, Elke M. G. J.
    Spuls, Phyllis I.
    Lecluse, Lidian L. A.
    [J]. JAMA DERMATOLOGY, 2014, 150 (02) : 130 - 136
  • [6] Key findings towards optimising adalimumab treatment: the concentration-effect curve
    Pouw, Mieke F.
    Krieckaert, Charlotte L.
    Nurmohamed, Michael T.
    van der Kleij, Desiree
    Aarden, Lucien
    Rispens, Theo
    Wolbink, Gertjan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 513 - 518
  • [7] Antibodies to constant domains of therapeutic monoclonal antibodies: Anti-hinge antibodies in immunogenicity testing
    Rispens, Theo
    de Vrieze, Henk
    de Groot, Els
    Wouters, Diana
    Stapel, Steven
    Wolbink, Gerrit J.
    Aarden, Lucien A.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 375 (1-2) : 93 - 99
  • [8] Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody
    Rispens, Theo
    van Leeuwen, Astrid
    Vennegoor, Anke
    Killestein, Joep
    Aalberse, Rob C.
    Wolbink, Gerrit J.
    Aarden, Lucien A.
    [J]. ANALYTICAL BIOCHEMISTRY, 2011, 411 (02) : 271 - 276
  • [9] A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients
    van Schouwenburg, Pauline A.
    Bartelds, Geertje M.
    Hart, Margreet H.
    Aarden, Lucien
    Wolbink, Gerrit Jan
    Wouters, Diana
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 362 (1-2) : 82 - 88
  • [10] Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
    Wolbink, GJ
    Vis, M
    Lems, W
    Voskuyl, AE
    de Groot, E
    Nurmohamed, MT
    Stapel, S
    Tak, PP
    Aarden, L
    Dijkmans, B
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 711 - 715
1